Zymeworks’ leading-edge ZymeCAD™ protein engineering technology platform has enabled the development of a diverse portfolio of proprietary antibody and antibody alternative products.

Platform Technologies

Indication Partnering Discovery In vitro Ex vivo In vivo Clinical
Azymetric™ Scaffold Multiple Merck
AlbuCORE™ Scaffold Multiple
EFECT™ Platform Oncology, Autoimmune
HL‧Max™ Platform Multiple

Therapeutics Pipeline

Program 1 Oncology
Program 2 Not Disclosed